Diabetes is accompanied by changes in the levels of proteins involved in endosomal GLUT4 trafficking in obese human skeletal muscle

Abstract Introduction The regulated delivery of the glucose transporter GLUT4 from intracellular stores to the plasma membrane underpins insulin‐stimulated glucose transport. Insulin‐stimulated glucose transport is impaired in skeletal muscle of patients with type‐2 diabetes, and this may arise beca...

Full description

Bibliographic Details
Main Authors: Rachel Livingstone, Nia J. Bryant, James G. Boyle, John R. Petrie, Gwyn W. Gould
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
Online Access:https://doi.org/10.1002/edm2.361
_version_ 1818050467829121024
author Rachel Livingstone
Nia J. Bryant
James G. Boyle
John R. Petrie
Gwyn W. Gould
author_facet Rachel Livingstone
Nia J. Bryant
James G. Boyle
John R. Petrie
Gwyn W. Gould
author_sort Rachel Livingstone
collection DOAJ
description Abstract Introduction The regulated delivery of the glucose transporter GLUT4 from intracellular stores to the plasma membrane underpins insulin‐stimulated glucose transport. Insulin‐stimulated glucose transport is impaired in skeletal muscle of patients with type‐2 diabetes, and this may arise because of impaired intracellular trafficking of GLUT4. However, molecular details of any such impairment have not been described. We hypothesized that GLUT4 and/or levels of proteins involved in intracellular GLUT4 trafficking may be impaired in skeletal muscle in type‐2 diabetes and tested this in obese individuals without and without type‐2 diabetes. Methods We recruited 12 participants with type‐2 diabetes and 12 control participants. All were overweight or obese with BMI of 25–45 kg/m2. Insulin sensitivity was measured using an insulin suppression test (IST), and vastus lateralis biopsies were taken in the fasted state. Cell extracts were immunoblotted to quantify levels of a range of proteins known to be involved in intracellular GLUT4 trafficking. Results Obese participants with type‐2 diabetes exhibited elevated fasting blood glucose and increased steady state glucose infusion rates in the IST compared with controls. Consistent with this, skeletal muscle from those with type‐2 diabetes expressed lower levels of GLUT4 (30%, p = .014). Levels of Syntaxin4, a key protein involved in GLUT4 vesicle fusion with the plasma membrane, were similar between groups. By contrast, we observed reductions in levels of Syntaxin16 (33.7%, p = 0.05), Sortilin (44%, p = .006) and Sorting Nexin‐1 (21.5%, p = .039) and −27 (60%, p = .001), key proteins involved in the intracellular sorting of GLUT4, in participants with type‐2 diabetes. Conclusions We report significant reductions of proteins involved in the endosomal trafficking of GLUT4 in skeletal muscle in obese people with type 2 diabetes compared with age‐ and weight‐matched controls. These abnormalities of intracellular GLUT4 trafficking may contribute to reduced whole body insulin sensitivity.
first_indexed 2024-12-10T10:53:57Z
format Article
id doaj.art-a6887227242943f8bbaed46984d0ab8e
institution Directory Open Access Journal
issn 2398-9238
language English
last_indexed 2024-12-10T10:53:57Z
publishDate 2022-09-01
publisher Wiley
record_format Article
series Endocrinology, Diabetes & Metabolism
spelling doaj.art-a6887227242943f8bbaed46984d0ab8e2022-12-22T01:51:56ZengWileyEndocrinology, Diabetes & Metabolism2398-92382022-09-0155n/an/a10.1002/edm2.361Diabetes is accompanied by changes in the levels of proteins involved in endosomal GLUT4 trafficking in obese human skeletal muscleRachel Livingstone0Nia J. Bryant1James G. Boyle2John R. Petrie3Gwyn W. Gould4Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow UKDepartment of Biology University of York York UKSchool of Medicine University of Glasgow Glasgow UKInstitute of Cardiovascular and Medical Sciences University of Glasgow Glasgow UKInstitute of Molecular Cell and Systems Biology University of Glasgow Glasgow UKAbstract Introduction The regulated delivery of the glucose transporter GLUT4 from intracellular stores to the plasma membrane underpins insulin‐stimulated glucose transport. Insulin‐stimulated glucose transport is impaired in skeletal muscle of patients with type‐2 diabetes, and this may arise because of impaired intracellular trafficking of GLUT4. However, molecular details of any such impairment have not been described. We hypothesized that GLUT4 and/or levels of proteins involved in intracellular GLUT4 trafficking may be impaired in skeletal muscle in type‐2 diabetes and tested this in obese individuals without and without type‐2 diabetes. Methods We recruited 12 participants with type‐2 diabetes and 12 control participants. All were overweight or obese with BMI of 25–45 kg/m2. Insulin sensitivity was measured using an insulin suppression test (IST), and vastus lateralis biopsies were taken in the fasted state. Cell extracts were immunoblotted to quantify levels of a range of proteins known to be involved in intracellular GLUT4 trafficking. Results Obese participants with type‐2 diabetes exhibited elevated fasting blood glucose and increased steady state glucose infusion rates in the IST compared with controls. Consistent with this, skeletal muscle from those with type‐2 diabetes expressed lower levels of GLUT4 (30%, p = .014). Levels of Syntaxin4, a key protein involved in GLUT4 vesicle fusion with the plasma membrane, were similar between groups. By contrast, we observed reductions in levels of Syntaxin16 (33.7%, p = 0.05), Sortilin (44%, p = .006) and Sorting Nexin‐1 (21.5%, p = .039) and −27 (60%, p = .001), key proteins involved in the intracellular sorting of GLUT4, in participants with type‐2 diabetes. Conclusions We report significant reductions of proteins involved in the endosomal trafficking of GLUT4 in skeletal muscle in obese people with type 2 diabetes compared with age‐ and weight‐matched controls. These abnormalities of intracellular GLUT4 trafficking may contribute to reduced whole body insulin sensitivity.https://doi.org/10.1002/edm2.361clinical medicinediabetesmetabolic disease
spellingShingle Rachel Livingstone
Nia J. Bryant
James G. Boyle
John R. Petrie
Gwyn W. Gould
Diabetes is accompanied by changes in the levels of proteins involved in endosomal GLUT4 trafficking in obese human skeletal muscle
Endocrinology, Diabetes & Metabolism
clinical medicine
diabetes
metabolic disease
title Diabetes is accompanied by changes in the levels of proteins involved in endosomal GLUT4 trafficking in obese human skeletal muscle
title_full Diabetes is accompanied by changes in the levels of proteins involved in endosomal GLUT4 trafficking in obese human skeletal muscle
title_fullStr Diabetes is accompanied by changes in the levels of proteins involved in endosomal GLUT4 trafficking in obese human skeletal muscle
title_full_unstemmed Diabetes is accompanied by changes in the levels of proteins involved in endosomal GLUT4 trafficking in obese human skeletal muscle
title_short Diabetes is accompanied by changes in the levels of proteins involved in endosomal GLUT4 trafficking in obese human skeletal muscle
title_sort diabetes is accompanied by changes in the levels of proteins involved in endosomal glut4 trafficking in obese human skeletal muscle
topic clinical medicine
diabetes
metabolic disease
url https://doi.org/10.1002/edm2.361
work_keys_str_mv AT rachellivingstone diabetesisaccompaniedbychangesinthelevelsofproteinsinvolvedinendosomalglut4traffickinginobesehumanskeletalmuscle
AT niajbryant diabetesisaccompaniedbychangesinthelevelsofproteinsinvolvedinendosomalglut4traffickinginobesehumanskeletalmuscle
AT jamesgboyle diabetesisaccompaniedbychangesinthelevelsofproteinsinvolvedinendosomalglut4traffickinginobesehumanskeletalmuscle
AT johnrpetrie diabetesisaccompaniedbychangesinthelevelsofproteinsinvolvedinendosomalglut4traffickinginobesehumanskeletalmuscle
AT gwynwgould diabetesisaccompaniedbychangesinthelevelsofproteinsinvolvedinendosomalglut4traffickinginobesehumanskeletalmuscle